After gains of 4.0% this morning, Insmed shares are now trading at $74.56. Read below for the essential facts about this stock:
-
Insmed has logged a 197.3% 52 week change, compared to 33.0% for the S&P 500
-
INSM has an average analyst rating of buy and is -15.03% away from its mean target price of $87.75 per share
-
Its trailing earnings per share (EPS) is $-5.41, which brings its trailing Price to Earnings (P/E) ratio to -13.8. The Health Care sector's average P/E ratio is 26.07
-
The company's forward earnings per share (EPS) is $-4.26 and its forward P/E ratio is -17.5
-
The company has a Price to Book (P/B) ratio of 320.0 in contrast to the Health Care sector's average P/B ratio is 3.53
-
The current ratio is currently 4.1, which consists in its liquid assets divided by any liabilities due within in the next 12 months
-
The company's free cash flow for the last fiscal year was $-549535000 and the average free cash flow growth rate is -14.3%
-
Insmed's revenues have an average growth rate of 33.1% with operating expenses growing at 24.1%. The company's current operating margins stand at -244.8%